Bristol-Myers Squibb (BMY) PT Bumped $10 to $75 But Hold Unchanged - Jefferies
Tweet Send to a Friend
Jefferies analyst, Jeffrey Holford, raised his revenue and EPS estimates on Bristol-Myers Squibb Co. (NYSE: BMY) based on a faster ...
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE